Topic

Tysabri (natalizumab)

A collection of 26 issues

How to Get Tysabri (natalizumab) Covered by Aetna CVS Health in North Carolina: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Tysabri Covered by Aetna CVS Health in North Carolina Tysabri (natalizumab) requires prior authorization from Aetna CVS Health with mandatory TOUCH Prescribing Program enrollment, recent JCV antibody testing, and brain MRI documentation. Submit requests via phone (1-855-582-2025), fax (1-855-330-1716), or mail with complete medical records. If denied,
7 min read

How to Get Tysabri (Natalizumab) Covered by Cigna in Georgia: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Tysabri Covered by Cigna in Georgia Cigna requires prior authorization for Tysabri (natalizumab) in Georgia with strict medical necessity criteria including TOUCH program enrollment, failed first-line DMTs, and comprehensive safety monitoring. Start by having your neurologist submit a PA request with documented step therapy failures, JCV antibody
6 min read

How to Get Tysabri (Natalizumab) Covered by UnitedHealthcare in Virginia: Complete Appeals Guide with Forms and Timelines

Answer Box: Getting Tysabri Covered by UnitedHealthcare in Virginia UnitedHealthcare requires prior authorization for Tysabri (natalizumab) through OptumRx, with mandatory TOUCH program enrollment and documentation of failed prior therapies. In Virginia, after internal appeals, you can request external review through the State Corporation Commission Bureau of Insurance within 120 days.
5 min read

How to Get Tysabri (Natalizumab) Covered by UnitedHealthcare in Washington: Appeals, Prior Authorization & State Protections

Quick Answer: Getting Tysabri Covered in Washington UnitedHealthcare requires prior authorization for Tysabri (natalizumab) through OptumRx before dispensing. You must be enrolled in the FDA-required TOUCH program and provide documentation of multiple sclerosis diagnosis with prior treatment failures. If denied, you have 180 days to file an internal appeal, followed
6 min read